The effect of two drugs used for the treatment of attention-deficit/hyperactivity disorder.
Brexanolone by Sage Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Post-Traumatic Stress Disorder (PTSD).